Cargando…
Targeting Purinergic Receptor P2RX1 Modulates Intestinal Microbiota and Alleviates Inflammation in Colitis
Inflammatory bowel disease (IBD) remains one of the most prevalent gastrointestinal diseases worldwide. Purinergic signaling has emerged as a promising therapeutic target of inflammation-associated diseases. However, little is known about the specific roles of purinergic receptors in IBD. In the pre...
Autores principales: | Wang, Xu, Yuan, Xiao, Su, Yuting, Hu, Jing, Ji, Qian, Fu, Shengqiao, Li, Rongkun, Hu, Lipeng, Dai, Chunhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329583/ https://www.ncbi.nlm.nih.gov/pubmed/34354708 http://dx.doi.org/10.3389/fimmu.2021.696766 |
Ejemplares similares
-
Control of Gut Inflammation by Modulation of Purinergic Signaling
por: Vuerich, Marta, et al.
Publicado: (2020) -
Purinergic Signaling in Pulmonary Inflammation
por: Le, Thanh-Thuy T., et al.
Publicado: (2019) -
Editorial: Purinergic Signaling and Inflammation
por: Yuan, Xiaoyi, et al.
Publicado: (2021) -
P2rx4 deficiency in mice alleviates allergen-induced airway inflammation
por: Zech, Andreas, et al.
Publicado: (2016) -
P2RX1-Involved Glycolytic Metabolism Supports Neutrophil Activation in Acute Pancreatitis
por: Wang, Xu, et al.
Publicado: (2021)